Physician profile
Ashish Sachdeva
NPI 1023049079
$11,040.69
in general payments reported to CMS, 2019-2025
76 companies · $1,582 in 2025
The $1,582 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,107 · 2020: $1,009 · 2021: $1,896 · 2022: $1,612 · 2023: $1,143 · 2024: $1,691 · 2025: $1,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,396 · Entertainment: $19.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,395.97 |
| Entertainment | $19.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,044.29 | 2019-2025 | Repatha, Krystexxa, Repatha |
| Pfizer INC. | $791.19 | 2019-2025 | |
| Glaxosmithkline, LLC. | $790.09 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $770.57 | 2019-2025 | Vraylar, Linzess, Viberzi |
| Astrazeneca Pharmaceuticals Lp | $741.69 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Astellas Pharma US INC | $526.65 | 2019-2025 | Veozah, Myrbetriq |
| Abbott Laboratories | $503.82 | 2019-2025 | Freestyle Libre 3, Jot Dx, Id Now Instrument |
| Novo Nordisk INC | $433.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $302.24 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $268.13 | 2023-2025 | Gemtesa |
| Sunovion Pharmaceuticals INC. | $266.70 | 2021-2022 | |
| Lilly USA, LLC | $264.35 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Edwards Lifesciences Corporation | $259.17 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $216.68 | 2019-2025 | Xifaxan, Trulance |
| Allergan, INC. | $206.23 | 2019-2020 |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $204.45 | 2024-2025 | |
| Medtronic, INC. | $183.05 | 2021-2025 | Intellis Adaptivestim, Symplicity G3, Minimed 780g |
| Nestle Healthcare Nutrition INC. | $167.49 | 2020-2022 | |
| Lucid Diagnostics INC. | $167.29 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.52 | 2019-2025 | Jascayd |
| Pacira Therapeutics, INC. | $155.82 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $141.84 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $140.86 | 2024 | Uptravi, Opsumit |
| Lundbeck LLC | $132.45 | 2019-2024 | Rexulti |
| Inspire Medical Systems, INC. | $129.94 | 2023-2025 | Inspire |
| Boston Scientific Corporation | $113.37 | 2020-2025 | Watchman Flx, General - Therapies |
| Kowa Pharmaceuticals America, INC. | $112.13 | 2019-2023 | Livalo, Seglentis |
| Dexcom, INC. | $110.44 | 2021-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $110.37 | 2019-2022 | |
| Philips North America LLC | $106.54 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Intuitive Surgical, INC. | $100.00 | 2023 | Da Vinci Surgical System |
| Optos, INC. | $90.42 | 2020-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Aimmune Therapeutics, INC. | $73.22 | 2025 | Zenpep |
| Otsuka America Pharmaceutical, INC. | $65.21 | 2023-2025 | Rexulti |
| Cleerly, INC. | $58.30 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Radius Health, INC. | $57.35 | 2020 | |
| Mannkind Corporation | $54.88 | 2019-2023 | Afrezza |
| Amarin Pharma, INC. | $53.33 | 2021-2022 | |
| Biogen, INC. | $47.13 | 2020-2021 | |
| Medtronic USA, INC. | $46.48 | 2019-2020 | |
| Daiichi Sankyo INC. | $45.17 | 2019-2023 | Injectafer |
| Teva Pharmaceuticals USA, INC. | $40.13 | 2021-2025 | Ajovy |
| Biohaven Pharmaceutical Holding Company Ltd. | $37.59 | 2022 | |
| Glaukos Corporation | $37.18 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $36.98 | 2020-2021 | |
| Exact Sciences Corporation | $36.88 | 2024-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $35.72 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.44 | 2019 | |
| Ge Healthcare | $34.41 | 2019-2020 | |
| Intra-Sana Laboratories | $32.01 | 2023-2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Ironwood Pharmaceuticals, INC | $29.28 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $27.89 | 2019 | |
| Melinta Therapeutics, LLC | $26.52 | 2019 | |
| Amag Pharmaceuticals, INC. | $25.94 | 2019 | |
| Hikma Pharmaceuticals USA | $24.54 | 2019-2020 | |
| Corium, LLC | $22.95 | 2023 | Adlarity |
| Alexion Pharmaceuticals, INC. | $22.73 | 2024 | Ultomiris |
| Corcept Therapeutics | $22.52 | 2025 | Korlym |
| Esperion Therapeutics, INC. | $21.87 | 2024 | Nexletol |
| Kyowa Kirin, INC. | $21.85 | 2025 | |
| Novartis Pharmaceuticals Corporation | $21.72 | 2022 | |
| Strongbridge US INC. | $21.68 | 2020 | |
| Globus Medical, INC. | $19.80 | 2025 | Omnia |
| Alnylam Pharmaceuticals INC. | $19.68 | 2022 | |
| Orthogenrx INC. | $18.94 | 2019 | |
| Verity Pharmaceuticals INC. | $18.23 | 2025 | Tlando |
| Abiomed | $18.10 | 2024 | Impella |
| Xeris Pharmaceuticals, INC. | $17.35 | 2023 | Gvoke Hypopen |
| Phadia US INC. | $16.68 | 2022 | |
| Horizon Therapeutics Plc | $15.84 | 2019 | |
| Sk Life Science, INC. | $15.34 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.13 | 2021 | |
| Currax Pharmaceuticals LLC | $14.20 | 2022 | |
| Genentech USA, INC. | $13.47 | 2019 | |
| Alfasigma USA, INC. | $11.62 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Repatha $300Gemtesa $268Sapien 3 Ultra Resilia $218Otezla $214Leqembi $204Rexulti $178Veozah $177Airsupra $172Kerendia $168Farxiga $150Opsumit $141Uptravi $141Breztri $139Krystexxa $138Inspire $130Rybelsus $124Ozempic $124Freestyle Libre 3 $104Nurtec Odt $104Trelegy Ellipta $104Da Vinci Surgical System $100Linzess $99.98Vraylar $81.74Zenpep $73.22Paxlovid $70.73Tzield $68.12Eliquis $64.69Wegovy $63.93Creon $63.43Xifaxan $59.94Cleerly Labs $58.30Cleerly Ischemia $58.30Intellis Adaptivestim $58.24Comirnaty $55.64Prevnar 20 $55.64Watchman Flx $53.36Qulipta $52.23Ubrelvy $52.23Jot Dx $50.15Trulance $45.09Livalo $43.16Seglentis $43.16Mounjaro $41.97Arexvy $40.82Abrysvo $40.10Oct Ophthalmoscope $39.72Panoramic Ophthalmoscope $39.72Cologuard Collection Kit $36.88Shingrix $34.04Reltone 400 Mg $32.01Reltone 200 Mg $32.01Glycate $32.01Id Now Instrument $29.94Evenity $29.83General - Therapies $29.15Zepbound $28.90Kisunla $27.92Injectafer $27.14Ambulatory Monitoring & Diagnostics Undivided $26.52Amyvid $23.95Myrbetriq $23.84Ajovy $23.46Eterna $23.40Adlarity $22.95Ultomiris $22.73Korlym $22.52Symplicity G3 $22.25Nexletol $21.87Crysvita $21.85Tacticath Ablation Catheter, Sensor Enabled $21.02Edwards Sapien 3 Ultra Transcatheter Heart Valve $21.01Edwards Sapien 3 Transcatheter Heart Valve (Thv) $20.37Nfc-700 $19.86Omnia $19.80Zavzpret $18.46Tlando $18.23Impella $18.10Freestyle Libre 2 $17.91Minimed 780g $17.67Gvoke Hypopen $17.35Dexcom G6 Transmitter $16.65Viberzi $15.32Jascayd $15.06Afrezza $14.92Jardiance $14.63Proclaim $13.79Trulicity $13.07
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Sachdeva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.